Tirzepatide CAS:2023788-19-2 Mea Hana Mea Hoʻolako Kiʻi Hōʻike ʻia

Tirzepatide CAS:2023788-19-2 Mea Hoʻolako Mea Hana

Ua hoʻomohala ʻia ʻo Tirzepatide ma ke ʻano he agonist ʻelua i ka GLP-1 a me ka gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018).E like me ka GLP-1, ʻo GIP kahi hormone incretin e hana ana e hoʻoulu i ka huna ʻana o ka insulin. Aia ʻo Tirzepatide i ka pae 3 o ka hoʻomohala ʻana no nā pākeke me ka momona a i ʻole ke kaumaha me ka comorbidity pili i ke kaumaha a aia i kēia manawa ma lalo o ka loiloi kānāwai ma ke ʻano he lapaʻau no nā pākeke me ka maʻi maʻi type 2 .Ke aʻo ʻia nei ma ke ʻano he lāʻau lapaʻau no ka steatohepatitis non-alcoholic (NASH) a me ka pau ʻole o ka naʻau me ka ʻāpana ejection i mālama ʻia (HFpEF).

Kauoha a Noi Manao

Huahana Huahana

Hoʻohana a me ka hopena

Hoʻohana ʻia ʻo Tirzepatide me kahi papaʻai kūpono a me ka papahana hoʻoikaika kino e kāohi i ke kō koko kiʻekiʻe i ka poʻe me ka maʻi maʻi type 2.ʻO ka hoʻomalu ʻana i ke kō koko kiʻekiʻe e kōkua i ka pale ʻana i ka pōʻino o nā puʻupaʻa, ka makapō, nā pilikia nerve, ka nalowale o nā lālā, a me nā pilikia o ka hana moe kolohe. ʻOi aku ka pili o Tirzepatide i nā mea loaʻa GIP ma mua o nā mea loaʻa GLP-1, a ua hōʻike ʻia kēia ʻano agonist ʻelua e hoʻoemi nui aʻe. ʻO ka hyperglycemia i hoʻohālikelike ʻia me kahi agonist receptor GLP-1 koho.Ua hōʻike ʻia nā haʻawina hōʻailona ma muli o ka tirzepatide e hoʻohālikelike i nā hana o ka GIP kūlohelohe i ka mea loaʻa GIP.

Laʻana Huahana

Hoʻopili huahana:

ʻIke hou aku:

Huina	Na
Hoʻāʻo	99%
Ka nana aku	Pauda keʻokeʻo
CAS No.	2023788-19-2
Hoʻopili	25KG
Ola Pahu	2 makahiki
Waihona	E mālama ma kahi maloʻo a maloʻo
Palapala hōʻoia	ISO.